Jessica Couch

Jessica Couch has extensive experience in the field of translational science and portfolio strategy. Jessica began their career in 2004 as a Postdoctoral Associate at the University of Florida. In 2006, they moved to Genzyme as a Scientist. In 2008, they joined Genentech and served as a Scientist, Senior Scientist, and Project Team Leader. In 2022, they began their current role as VP Translational Science and Portfolio Strategy at ReCode Therapeutics.

Jessica Couch obtained their PhD in Neuroscience from the University of Virginia in 2003, following a BS in Psychology from the University of Florida in 1998. Jessica also holds a DABT certification from the American Board of Toxicology.